R&D Pipeline News - Therapeutic Area Edition: 1-Month Subscription
R&D Pipeline News is your weekly tool for analysis of biopharmaceutical R&D. It is available by monthly or annual subscription. The annual subscription consists of 50 issues, the monthly of four or five issues.
R&D Pipeline News Therapeutic Area Edition will keep you up-to-date with the latest R&D projects of the biopharmaceutical industry, with all the relevant treatment modalities and with competitive information about ongoing R&D projects for a given Target, Technology or Company.
R&D Pipeline News Therapeutic Area Edition will keep you up-to-date with the latest R&D projects of the biopharmaceutical industry, with all the relevant treatment modalities and with competitive information about ongoing R&D projects for a given Target, Technology or Company.
The R&D information is presented in an easy- and rapid-to-screen tabular format and sorted by Product Categories.
The Therapeutic Area Edition lists the News in groups according to the product category, e.g. antibodies or vaccines etc. The product is delivered every week via e-mail as a PDF document directly to your desktop.
One-month and one-year subscriptions are available as single user license, departmental license, site license and global license. After completion of the purchase process, we will get in touch with you to gather the e-mail addresses of your institution for individual desktop delivery.
What is R&D Pipeline News?
R&D Pipeline News is a premier information source about research and development (R&D) projects in the pipeline of the biopharmaceutical industry and is directed to all stakeholders in R&D. R&D Pipeline News covers all relevant treatment modalities, incl. drugs, medical devices, biomaterials, combination products, cell therapy and drug delivery products. The news are retrieved from business as well as scientific communications over all stages of the R&D process - from research to approval.
Key Product Features- Weekly tool for R&D analysis;
- Individual e-mail delivery for multi-users;
- 8000+ unique compounds covered;
- Independent and expert editorial staff;
- Coverage of all treatment modalities;
- Featured company pipelines;
- Featured target and indication pipelines;
- Systematic presentation format for easy and rapid screening of news.
- R&D Professionals;
- Consultants;
- Competitive & Business Intelligence Professionals;
- Scientific & Business Information Services;
- Drug Delivery Technologists;
- Project Leaders and Therapeutic Area Heads;
- Business Development & Licensing;
- Strategic Planning & Analysis;
- Investment and FondsManagers;
- Technology & Regulatory Affaisrs Specialists;
- Project & Product Developers;
- R&D Directors and Managers;
- Marketing & Sales;
- Biomanufacturing & Operations;
- Research Analysts.
- To keep up-to-date. Examine the who, what, when, where of biotechnology R&D.
- To benchmark your company against the competition. Keep an eye on your competitors' projects and developments, in which stage they are, their achievements, handicaps, etc...and find out where you are standing in the market.
- To save time in your research. Get the crucial information, in a one-shot tabular view/screen sorted by Therapeutic Areas or Product Categories, and deepen easily in those articles in which you are interested with just one-click.
- To identify new business enterprises Recognize new business opportunities: joint ventures, licensing partners, co-marketing partners, etc..
Inside R&D Pipeline News
Tables with news described by:
- Product Names;
- Target / Mechanism of Action;
- Class of Compound;
- Company;
- Therapeutic Area or Product Category;
- Indication;
- R&D stage;
- Key message;
- Hyperlink to original news document.
Company Profiles; Featured Pipelines (Target, Technology, Indication); Technology News; R&D Collaboration Deals; R&D Licensing Deals; Mergers & Acquisitions
Source of Information- Companypress releases;
- Companyreports;
- Companyhomepages and presentations;
- Databasesand directories;
- Businessmeetings & trade shows;
- RegulatoryAgencies;
- Biotech& pharma organizations;
- Scientificcommunications & publications,
- Review articles;
- Directenquiries;
- Disease& adacemic homepages;
- Investor portfolios;
- Internet monitoring.
